Euro-Med Laboratories Phil., Inc. (PSE:EURO)
1.030
-0.010 (-0.96%)
At close: May 12, 2026
PSE:EURO Balance Sheet
Financials in millions PHP. Fiscal year is January - December.
Millions PHP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,206 | 857.62 | 881.35 | 615.72 | 554.5 |
Trading Asset Securities | 312.65 | 233.56 | 202.01 | 190.6 | 173.39 |
Cash & Short-Term Investments | 1,518 | 1,091 | 1,083 | 806.31 | 727.89 |
Cash Growth | 39.15% | 0.72% | 34.36% | 10.77% | -0.62% |
Accounts Receivable | 1,841 | 1,807 | 1,592 | 1,439 | 1,319 |
Other Receivables | 113.84 | 132.2 | 111.52 | 43.87 | 44.07 |
Receivables | 1,955 | 1,940 | 1,703 | 1,483 | 1,363 |
Inventory | 1,582 | 1,742 | 1,693 | 1,537 | 1,264 |
Prepaid Expenses | 317.8 | 330.91 | 321.84 | 317.88 | 296.64 |
Other Current Assets | 249.44 | 214.64 | 334.27 | 283.44 | 259.4 |
Total Current Assets | 5,623 | 5,318 | 5,135 | 4,428 | 3,911 |
Property, Plant & Equipment | 4,847 | 4,933 | 4,961 | 4,961 | 5,052 |
Long-Term Investments | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Other Intangible Assets | 270.13 | 268.13 | 268.13 | 268.13 | 268.21 |
Long-Term Deferred Tax Assets | 115.32 | 122.26 | 109.15 | 97.15 | 105.95 |
Long-Term Deferred Charges | 12.65 | 12.65 | 21.07 | 38.79 | 51.44 |
Other Long-Term Assets | 276.71 | 295.41 | 268.76 | 266.17 | 302.82 |
Total Assets | 11,145 | 10,950 | 10,764 | 10,059 | 9,691 |
Accounts Payable | 316.7 | 349.49 | 477.38 | 345.59 | 301.14 |
Accrued Expenses | 113.64 | 139.51 | 104.6 | 69.31 | 85.39 |
Short-Term Debt | 2,998 | 3,040 | 3,014 | 2,633 | 2,283 |
Current Portion of Long-Term Debt | 294.91 | 285.65 | 209.75 | 184.3 | 195.08 |
Current Portion of Leases | 56.55 | 66.98 | 58.6 | 60.82 | 49.18 |
Current Income Taxes Payable | 50.02 | 26.61 | 51.64 | 31.18 | 22.8 |
Current Unearned Revenue | 2.12 | 0.37 | 1.81 | 0.75 | 0.4 |
Other Current Liabilities | 0.42 | 0.22 | 0.11 | 0.62 | 0.6 |
Total Current Liabilities | 3,833 | 3,909 | 3,918 | 3,326 | 2,937 |
Long-Term Debt | 857.3 | 774.25 | 666.91 | 663.62 | 788.75 |
Long-Term Leases | 105.38 | 125.53 | 89.48 | 138.91 | 105.29 |
Pension & Post-Retirement Benefits | 281.15 | 257.96 | 244.24 | 221.62 | 219.32 |
Total Liabilities | 5,076 | 5,067 | 4,919 | 4,350 | 4,051 |
Common Stock | 4,112 | 4,112 | 4,112 | 4,112 | 4,112 |
Additional Paid-In Capital | 66.61 | 66.61 | 66.61 | 66.61 | 66.61 |
Retained Earnings | 1,906 | 1,724 | 1,692 | 1,547 | 1,494 |
Comprehensive Income & Other | -16.75 | -19.77 | -25.15 | -16.52 | -31.79 |
Shareholders' Equity | 6,068 | 5,883 | 5,845 | 5,709 | 5,641 |
Total Liabilities & Equity | 11,145 | 10,950 | 10,764 | 10,059 | 9,691 |
Total Debt | 4,312 | 4,293 | 4,039 | 3,681 | 3,421 |
Net Cash (Debt) | -2,794 | -3,202 | -2,956 | -2,874 | -2,693 |
Net Cash Per Share | -0.68 | -0.78 | -0.72 | -0.70 | -0.65 |
Filing Date Shares Outstanding | 4,112 | 4,112 | 4,112 | 4,112 | 4,112 |
Total Common Shares Outstanding | 4,112 | 4,112 | 4,112 | 4,112 | 4,112 |
Working Capital | 1,790 | 1,409 | 1,217 | 1,102 | 973.51 |
Book Value Per Share | 1.48 | 1.43 | 1.42 | 1.39 | 1.37 |
Tangible Book Value | 5,798 | 5,615 | 5,577 | 5,441 | 5,372 |
Tangible Book Value Per Share | 1.41 | 1.37 | 1.36 | 1.32 | 1.31 |
Land | 166.77 | 166.77 | 173.34 | 131.83 | 106.59 |
Buildings | 3,153 | 3,043 | 2,981 | 2,816 | 2,777 |
Machinery | 6,657 | 6,499 | 6,365 | 6,278 | 6,254 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.